Svea Vaccin and Vif Research and Travel Grant on Tuberculosis Vaccine – 2021

Svea Vaccin and Världsinfektionsfonden announce a research travel grant of up to 25,000 SEK for young researchers for research on a new tuberculosis vaccine.

The research may include the development of new vaccine candidates and adjuvants, markers for vaccine-induced immune responses, preclinical and clinical studies. Indirect costs are not allowed.

The work is expected to take place during 2022. The applicant is supposed to be registered at a Swedish university, at least at master’s level.

Deadline 5 December 2021.

The application must be formatted as follows:

No longer than two (2) pages
12-point font
Single line spacing
Arial or Times New Roman font
Proposals that do not adhere to these restrictions may be blocked from review.
Include budget and time plan in the proposal.

Submit your proposal to Also submit a CV in the application letter.

Successful applicants will receive funding in December 2021 and are expected to write a 2-page report for Vif that may be used for communication purposes at

For questions, please write to